Skip to main content
Fig. 9 | Journal of Ovarian Research

Fig. 9

From: Novel prognostic marker TGFBI affects the migration and invasion function of ovarian cancer cells and activates the integrin αvβ3-PI3K-Akt signaling pathway

Fig. 9

Mechanism exploration of TGFBI functions 3. A Wound healing assay for TGFBI EO SKOV-3 cells treated with integrin αvβ3 inhibitor Cyclo (-RGDyK) at 80 nM. B Wound healing assay for TGFBI EO Caov-3 cells treated with integrin αvβ3 inhibitor Cyclo (-RGDyK) at 80 nM. C Transwell assay for TGFBI EO SKOV-3 cells treated with integrin αvβ3 inhibitor Cyclo (-RGDyK) at 80 nM. D for TGFBI EO Caov-3 cells treated with integrin αvβ3 inhibitor Cyclo (-RGDyK) at 80 nM. EO over-expression, NS not significant *p < 0.05, **p < 0.01, ***p < 0.001

Back to article page

Journal of Ovarian Research

ISSN: 1757-2215

Contact us